Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001576419-25-000567·BIOCRYST PHARMACEUTICALS INC
Schedule 13G ownership disclosure
BIOCRYST PHARMACEUTICALS INC
Common Stock · CUSIP: 09058V103
Event date: 2025-03-31
- Filing-level shares
- 17,483,490
- Percent of class
- 8.4%
- BlackRock, Inc.
Shares: 17,483,490 · Class: 8.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001576419-25-000567
- Form type
- SCHEDULE 13G/A
- Filer
- BIOCRYST PHARMACEUTICALS INC
- CIK
- CIK 882796
- Filed
- Apr 17, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership